Guidelines for Stability Testing of Hormonal Products

1) Purpose

The purpose of this SOP is to outline the procedures for conducting stability studies on hormonal products. Hormonal products are susceptible to degradation due to environmental factors like temperature, light, and humidity. This SOP aims to determine their stability and establish appropriate storage conditions to ensure their safety and efficacy.

2) Scope

This SOP applies to all hormonal products, including tablets, capsules, injectables, and transdermal patches, handled or stored by the organization. It is intended for personnel involved in formulation, quality control, and regulatory compliance.

3) Responsibilities

Formulation Scientist: Responsible for designing the stability study and selecting appropriate analytical methods.

Quality Control (QC) Team: Responsible for conducting the required tests and recording data.

QA Team: Responsible for reviewing and approving the stability study protocol and final report.

4) Procedure

4.1 Study Design:

1. Identify stability-indicating parameters (e.g., potency, purity, dissolution rate, and content uniformity)
   

   “Unlock the Secrets of Drug Stability: Master the Principles and Practices for a Promising Pharmaceutical Future!”

   relevant to the hormonal product.
2. Define the storage conditions (e.g., room temperature, refrigeration, and controlled humidity) to be tested based on product characteristics and regulatory requirements.
3. Develop a study protocol that includes sampling schedules, analytical methods, and acceptance criteria.

4.2 Sample Preparation:

1. Prepare samples from representative batches according to standard manufacturing procedures.
2. Label samples appropriately with batch